Tumor-infiltrating lymphocytes and macrophages as a significant prognostic factor in biliary tract cancer.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 36693070.
- Also identified by DOI 10.1371/journal.pone.0280348 and PMC identifier 9873170.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The impact of tumor-infiltrating lymphocytes (TILs) and tumor-associated macrophages (TAMs) on the prognosis of biliary tract cancer (BTC) is not completely understood. Therefore, in our study, we investigated the effects of the various immune cells infiltration in tumor microenvironment (TME). A total of 130 patients with BTC who underwent surgical treatment at our institution were enrolled in this study. We retrospectively evaluated TILs and TAMs with immunohistochemical staining. With CD8-high, CD4-high, FOXP3-high, and CD68-low in TME as one factor, we calculated Immunoscore according to the number of factors. The high Immunoscore group showed significantly superior overall survival (OS) and recurrence-free survival (RFS) than the low Immunoscore group (median OS, 60.8 vs. 26.4 months, p = 0.001; median RFS not reached vs. 17.2 months, p < 0.001). Also, high Immunoscore was an independent good prognostic factor for OS and RFS (hazards ratio 2.05 and 2.41 and p = 0.01 and p = 0.001, respectively). High Immunoscore group had significantly superior OS and RFS and was an independent good prognostic factor for OS and RFS.
Medical subject headings
- Lymphocytes, Tumor-Infiltrating
- Biliary Tract Neoplasms